Cytokine profile of macrophage activation syndrome associated with Kawasaki disease - PubMed (original) (raw)

doi: 10.1016/j.cyto.2019.03.001. Epub 2019 Mar 14.

Masaki Shimizu 2, Keigo Nishida 1, Shuya Kaneko 1, Masaaki Usami 1, Naoto Sakumura 1, Hitoshi Irabu 1, Maiko Takakuwa 1, Natsumi Inoue 1, Mao Mizuta 1, Yasuhiro Ikawa 1, Shuhei Fujita 3, Akihiro Yachie 1

Affiliations

Cytokine profile of macrophage activation syndrome associated with Kawasaki disease

Asumi Jinkawa et al. Cytokine. 2019 Jul.

Abstract

The present study aimed to assess the kinetics of cytokine release and compare the accuracy of serum biomarkers for the diagnosis of macrophage activation syndrome (MAS) associated with Kawasaki disease (KD). Serum neopterin, interleukin (IL)-18, IL-6 and soluble tumour necrosis factor receptor type I (sTNFR-I) and sTNFR-II levels were determined using enzyme-linked immunosorbent assay in 78 patients with KD, including five with MAS. Results were compared to the clinical features of MAS. Serum neopterin, IL-18, sTNFR-II levels and sTNFR-II/I ratio were significantly elevated in KD patients with MAS compared to those in the acute phase. Receiver operating characteristic curve analysis revealed areas under the curve and cutoff values of neopterin, IL-18, sTNFR-II levels and sTNFR-II/I ratio were 0.9750/30.0 nmol/L, 0.9813/1165 ng/mL, 0.9969/16,600 pg/mL and 0.9875/4.475, respectively. Serum sTNFR-II levels correlated positively with disease activity. These findings indicate that overproduction of interferon (IFN)-γ and TNF-α reflected by increased serum levels of neopterin and sTNFR-II are closely associated with the pathogenesis of MAS associated with KD. Serum sTNFR-II levels might be a useful marker to diagnose the transition to MAS.

Keywords: Kawasaki disease; Macrophage activation syndrome; Soluble tumour necrosis factor receptor type II.

Copyright © 2019 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources